 |
Performance Improvement Strategies in Multiple Sclerosis: 2012-2013 Series |
The American Board of Psychiatry and Neurology (ABPN) has reviewed Performance Improvement Strategies in Multiple Sclerosis and has approved it as a Performance in Practice (PIP) and CME program—part of the overall ABPN Maintenance of Certification (MOC) program.
ENROLL
Med-IQ currently offers PI CME in the following areas:
|
Baltimore, MD—February 14, 2012—Med-IQ, an award-winning, ACCME-accredited provider of continuing medical education (CME), is pleased to announce the continuation of its complimentary, certified performance improvement (PI) CME initiative in multiple sclerosis (MS).
Performance Improvement Strategies in Multiple Sclerosis: 2012-2013 Series is approved as part of the American Board of Psychiatry and Neurology's (ABPN) Maintenance of Certification (MOC) program and meets the board's Performance in Practice (PIP) requirements. Participants can receive up to 20 AMA PRA Category 1 Credits™ while earning one unit towards ABPN's PIP MOC requirement. ABPN's MOC process requires neurologists with time-limited, 10-year certificates to complete three PIP units over their 10-year MOC cycle to remain board certified.
This three-stage initiative offers neurologists, physician assistants, and nurse practitioners who are involved in the care of patients with MS the opportunity to assess their practice methods against current evidence, expert consensus, and their peers’ practice in an effort to identify areas of improvement to enhance patient care.
The 2012-2013 series has been updated to incorporate the expanding knowledge base and expert recommendations on initiating, monitoring, and modifying disease-modifying therapies (DMTs), as well as assessing treatment response, identifying and managing suboptimal responders, and improving patient adherence to DMTs.
More than 675 neurologists and other healthcare professionals enrolled in Med-IQ's original 2010-2011 multiple sclerosis PI CME series. Based on a comprehensive practitioner needs analysis conducted as part of the original activity, the new series features a printable decision-support tool, offering clinicians an evidence- and expert consensus-based aid for selecting, monitoring, and switching DMTs. Additional educational activities include a complimentary CME publication and two Community of Practice audioconferences.
"Clinical research and progress in understanding the complex pathophysiology of MS have led to dramatic improvements in the recognition and management of this disease, including the development of several new immunomodulating agents," said Douglas R. Jeffery, MD, PhD, Director of the Multiple Sclerosis Center at Advance Neurology at Cornerstone Healthcare in Advance, NC. "By participating in this comprehensive PI CME initiative, clinicians will have access to consensus statements, recent developments, and new insights that can help improve care and, ultimately, outcomes for patients with MS."
| Faculty |
| |
Douglas R. Jeffery, MD, PhD (Chair)
Director, Multiple Sclerosis Center
Advance Neurology at Cornerstone Healthcare
Advance, NC
|
|
| |
Patricia K. Coyle, MD
Professor and Acting Chair
Department of Neurology
Stony Brook University Medical Center
Stony Brook, NY
|
|
| |
Mark S. Freedman, MD
Professor of Medicine (Neurology)
Senior Scientist, The Ottawa Hospital Research Institute
University of Ottawa
Director, Multiple Sclerosis Research Unit
The Ottawa Hospital-General Campus
Ottawa, Ontario, Canada
|
|
|
|
PI CME has been recognized as an important component of continuing professional development and may answer multiple credentialing and reporting needs. Med-IQ’s user-friendly PI CME platform is conducive to clinicians’ busy schedules, enabling them to participate while they practice. Each of the below stages can be completed online or with the help of the Med-IQ concierge team, which is available to assist participants at any time by answering questions and providing step-by-step instructions, tips, and reminders, as well as data entry assistance to prevent interruptions to patient care.
|
|
|
Stage A
Assess |
|
Assess your current practice against current evidence, expert consensus, and peers' practice |
|
|
|
|
|
|
|
|
|
|
|
Stage B
Apply |
|
Develop and follow your own improvement plan. |
|
|
|
|
|
|
|
|
|
|
|
Stage C
Evaluate |
|
Reassess your practice to measure the effects of your improvement plan |
|
|
|
|
|
|
|
|
|
|
|
|
|
"Based on the overwhelmingly positive response to Med-IQ's original MS PI CME initiative, we are pleased to now offer the enhanced 2012-2013 series. Clinicians need comprehensive, enduring education about practical strategies for improving patient care, and Med-IQ is dedicated to the ongoing delivery of these quality, complimentary PI CME activities," said William A. Mencia, MD, CCMEP, Vice President of Education and Medical Affairs at Med-IQ.
2010-2011 MS PI CME Participant Testimonials
"After the initial assessment of areas that required improvement, I incorporated this knowledge into my practice and noticed an immediate impact regarding patient care and satisfaction."
“I am improving communicating with my patients and trying to be sure that I ask each patient specifically about their symptoms at each visit.”
"I think this has improved my practice and the care I provide to my patients."
Performance Improvement Strategies in Multiple Sclerosis: 2012-2013 Series is approved for AMA PRA Category 1 Credit™ and is supported by an educational grant from Teva Neuroscience. For more information or to enroll, call (toll-free) 866 858 7434, e-mail concierge@med-iq.com, or visit www.pi-iq.com/multiplesclerosis.
About Med-IQ
Med-IQ, America’s most respected provider of continuing medical education (CME), inspires healthcare professionals through activities that deliver sophisticated outcomes-based educational designs with measurable results in professional competence and performance. Med-IQ received the Alliance for Continuing Education in the Health Professions' President’s Award (2012), Award for Outstanding CME Outcomes Assessment (2012), and William Campbell Felch Award for Outstanding Research in CME (2011). Med-IQ is accredited by the Accreditation Council for Continuing Medical Education (ACCME), the California Board of Registered Nursing (CBRN), and the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing medical education to physicians, nurses, and pharmacists, respectively. We are a leader in the development of performance improvement (PI) and quality improvement (QI) CME initiatives. To learn more about Med-IQ, visit www.Med-IQ.com, like us on Facebook, follow us on Twitter, connect with us on LinkedIn, and visit our YouTube channel.
For more information, contact: |
close
